High Vista Strategies LLC Cogent Biosciences, Inc. Transaction History
High Vista Strategies LLC
- $242 Million
- Q4 2024
A detailed history of High Vista Strategies LLC transactions in Cogent Biosciences, Inc. stock. As of the latest transaction made, High Vista Strategies LLC holds 279,673 shares of COGT stock, worth $2.09 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
279,673
Previous 225,633
23.95%
Holding current value
$2.09 Million
Previous $2.44 Million
10.47%
% of portfolio
0.9%
Previous 0.95%
Shares
7 transactions
Others Institutions Holding COGT
# of Institutions
190Shares Held
104MCall Options Held
157KPut Options Held
439K-
Kynam Capital Management, LP Princeton, NJ9.11MShares$67.9 Million4.5% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$54.4 Million0.0% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA6.96MShares$52 Million8.87% of portfolio
-
Commodore Capital LP New York, NY6.88MShares$51.3 Million5.38% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA6.23MShares$46.4 Million9.76% of portfolio
About Cogent Biosciences, Inc.
- Ticker COGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,758,300
- Market Cap $491M
- Description
- Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...